Abstract:Human serum has been intensively studied to identify biomarkers via global proteomic analysis. The altered O-glycoproteome is associated with human pathological state including cancer, inflammatory and degenerative diseases and is an attractive source of disease biomarkers. Because of the microheterogeneity and macroheterogeneity of O-glycosylation, site-specific O-glycosylation analysis in human serum is still challenging. Here, we developed a systematic strategy that combined multiple enzyme digestion, multidimensional separation for sample preparation and high-resolution tandem MS with Byonic software for intact O-glycopeptide characterization. We demonstrated that multiple enzyme digestion or multidimensional separation can make sample preparation more efficient and that EThcD is not only suitable for the identification of singly O-glycosylated peptides (50.3%) but also doubly (21.2%) and triply (28.5%) O-glycosylated peptides. Totally, with the strict scoring criteria, 499 non-redundant intact O-glycopeptides, 173 O-glycosylation sites and 6 types of O-glycans originating from 49 O-glycoprotein groups were identified in human serum, including 121 novel O-glycosylation sites. Currently, this is the largest data set of site-specific native O-glycoproteome from human serum samples. We expect that the strategies developed by this study will facilitate in-depth analyses of native O-glycoproteomes in human serum and provide opportunities to understand the functional roles of protein O-glycosylation in human health and diseases.BIOLOGICAL SIGNIFICANCE:The altered O-glycoproteome is associated with human pathological state and is an attractive source of disease biomarkers. However, site-specific O-glycosylation analysis is challenging because of the microheterogeneity (different glycoforms attached to one glycosylation site) and macroheterogeneity (site occupancy) of O-glycosylation. In this work, we developed a systematic strategy for intact O-glycopeptide characterization. This study took advantage of the inherent properties of the new fragmentation method called EThcD, which provides more complete fragmentation information about O-glycosylated peptides and a more confident site localization of O-glycans than collision-induced dissociation (HCD). We demonstrated that multiple enzyme digestion or multidimensional separation can make sample preparation more efficient and that EThcD was not only suitable for the identification of singly O-glycosylated peptides (50.3%) but also doubly (21.2%) and triply (28.5%) O-glycosylated peptides. Finally, we got a largest data set of site-specific native O-glycoproteome from human serum samples. Furthermore, quantitative analysis of intact O-glycopeptides from the serum samples of IgA nephropathy (IgAN) patients and healthy donors was performed, and the results showed the potential of the strategy to discover O-glycosylation biomarkers. We expect that the strategies developed by this study will facilitate in-depth analyses of native O-glycoproteomes in human serum and lead to exciting opportunities to understand the functional roles of protein O-glycosylation in human health and diseases.

Investigation Of Non-Enzymatic Glycosylation Of Human Serum Albumin Using Ion Trap-Time Of Flight Mass Spectrometry

Imaging of protein-specific glycosylation by glycan metabolic tagging and in situ proximity ligation.

Identification of Early Glycated Peptides of Albumin by a Method of Isotopic Labeling Combined with Neutral Loss Scan

Exploring glycated sites in human serum albumin: impact of sample processing techniques on detection and analysis

Mass spectrometric determination of early and advanced glycation in biology

Identification of Heavily Glycated Proteoforms by Hydrophilic-Interaction Liquid Chromatography and Native Size-Exclusion Chromatography – High-Resolution Mass Spectrometry

Proteomics Analysis of O-GalNAc Glycosylation in Human Serum by an Integrated Strategy

Glycomic Analysis by Glycoprotein Immobilization for Glycan Extraction and Liquid Chromatography on Microfluidic Chip.

Systems Analysis of Singly and Multiply O-glycosylated Peptides in the Human Serum Glycoproteome Via EThcD and HCD Mass Spectrometry.

Glycomic analysis using glycoprotein immobilization for glycan extraction.

Site-specific Profiling of Serum Glycoproteins Using N-linked Glycan and Glycosite Analysis Reveals Atypical N-Glycosylation Sites on Albumin and Alpha-1B-glycoprotein.

Study of Hemoglobin and Human Serum Albumin Glycation with Electrochemical Techniques

Discovery and validation of glucose-sensitive peptide biomarkers from human serum albumin to diagnose type 2 diabetes mellitus

A Rapid Method for Identifying Glycation Sites in Therapeutic Proteins by Isotopic Labeling with 13C6- Glucose

Characterisation of a new online nanoLC-CZE-MS platform and application for the glycosylation profiling of alpha-1-acid glycoprotein

Spectroscopic and in Silico Study of Binding Mechanism of Cynidine-3-o-glucoside with Human Serum Albumin and Glycated Human Serum Albumin.

Chromatographic Separation and Quantitative Analysis of Glycated Albumin in Human Saliva by Glucose Phenylosazone Spectrophotometric Assay

Effect of different glycation agents on Cu(II) binding to human serum albumin, studied by liquid chromatography, nitrogen microwave-plasma atomic-emission spectrometry, inductively-coupled-plasma mass spectrometry, and high-resolution molecular-mass spectrometry

A study on modification of Human Albumin by proteomic technique

Silver Nanoparticle Based Surface-Enhanced Raman Spectroscopy for Label-Free Discrimination of Diabetic Albumin under Near-Infrared Laser Excitation